4//SEC Filing
Protea Biosciences Group, Inc. 4
Accession 0001140361-16-073485
CIK 0001335103operating
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 1:01 PM ET
Size
5.2 KB
Accession
0001140361-16-073485
Insider Transaction Report
Form 4
TURNER STEPHEN C
DirectorCEO and Chairman of the Board
Transactions
- Purchase
Common Stock
2016-07-25$0.15/sh+20,000$2,980→ 2,197,372 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1462 to $0.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote 1 to this Form 4.
Documents
Issuer
Protea Biosciences Group, Inc.
CIK 0001335103
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001335103
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 1:01 PM ET
- Size
- 5.2 KB